Smith Jason Drew

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 62% 68% 82%
Transactions
19 5% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -23%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Smith Jason Drew's trades of Urogen Pharma Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-11 2026-02-03
S Sale
55,884 -20.3%
224.69
US$4,946,869 		55,884 -20.3% 224.69 US$4,946,869
2026-02-11 2026-02-03
S Sale
91,796 -30.1%
151.00
US$3,027,929 		91,796 -30.1% 151.00 US$3,027,929
2026-02-11 2026-02-03
S Sale
25,194 -48.4%
80.29
US$1,956,324 		25,194 -48.4% 80.29 US$1,956,324
2025-09-09 2025-09-08
PrS Proposed sale
1,520
18.88
US$28,698 		1,520 18.88 US$28,698
2025-09-09 2025-09-08
S Sale
1,520 -3.4%
19.11
US$29,047 		1,520 -3.4% 19.11 US$29,047
2025-07-30 2025-07-28
S Sale
7,522 -15.3%
19.14
US$143,971 		7,522 -15.3% 19.14 US$143,971
2025-07-29 2025-07-28
PrS Proposed sale
7,522
18.95
US$142,542 		7,522 18.95 US$142,542
2025-02-04 2025-01-31
S Sale
2,767 -7.8%
11.14
US$30,824 		2,767 -7.8% 11.14 US$30,824
2025-02-04 2025-01-31
S Sale
3,354 -10.1%
11.14
US$37,364 		3,354 -10.1% 11.14 US$37,364
2025-02-04 2025-01-31
S Sale
1,258 -4.5%
11.14
US$14,014 		1,258 -4.5% 11.14 US$14,014
2024-09-12 2024-09-09
S Sale
1,521 -5.7%
13.08
US$19,895 		1,521 -5.7% 13.08 US$19,895
2024-02-02 2024-01-31
S Sale
3,328 -12.4%
15.74
US$52,383 		3,328 -12.4% 15.74 US$52,383
2024-02-02 2024-01-31
S Sale
1,248 -5.9%
15.74
US$19,644 		1,248 -5.9% 15.74 US$19,644
2024-02-02 2024-01-31
S Sale
417 -2.2%
15.74
US$6,564 		417 -2.2% 15.74 US$6,564
2024-02-01 2024-01-31
PrS Proposed sale
4,993
15.83
US$79,039 		4,993 15.83 US$79,039
2023-09-05 2023-08-31
S Sale
3,800 -17.1%
18.01
US$68,438 		3,800 -17.1% 18.01 US$68,438
2023-02-02 2023-01-31
S Sale
1,227 -8.1%
10.12
US$12,417 		1,227 -8.1% 10.12 US$12,417
2023-02-02 2023-01-31
S Sale
409 -3.1%
10.12
US$4,139 		409 -3.1% 10.12 US$4,139
2022-09-02 2022-08-31
S Sale
3,606 -22.8%
7.21
US$25,999 		3,606 -22.8% 7.21 US$25,999
2022-02-02 2022-01-31
S Sale
414 -5.3%
7.58
US$3,138 		414 -5.3% 7.58 US$3,138
2021-12-02 2021-11-30
S Sale
3,803 -35.1%
12.03
US$45,750 		3,803 -35.1% 12.03 US$45,750
2021-05-18 2021-05-17
B Purchase
2,500 +inf%
15.71
US$39,275 		2,500 +inf% 15.71 US$39,275